XTX Topco’s Wave Life Sciences WVE Stock Holding History

XTX Topco’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.56M	Buy	439,933 +330,071	+300%	+$2.19M	0.03%	876
2026 Q1	$797K	Buy	+109,862	New	+$1.43M	0.01%	1616
2025 Q2	–	Sell	-27,792	Closed	-$225K	–	3270
2025 Q1	$225K	Buy	+27,792	New	+$304K	0.01%	1620
2024 Q4	–	Sell	-15,334	Closed	-$126K	–	3009
2024 Q3	$126K	Buy	+15,334	New	+$91.7K	0.01%	1565
2024 Q2	–	Sell	-46,837	Closed	-$289K	–	2542
2024 Q1	$289K	Buy	+46,837	New	+$235K	0.04%	890
2023 Q4	–	Sell	-32,280	Closed	-$186K	–	2223
2023 Q3	$186K	Sell	32,280 -29,181	-47%	-$133K	0.03%	1039
2023 Q2	$224K	Buy	+61,461	New	+$248K	0.04%	938
2022 Q4	–	Sell	-11,335	Closed	-$41K	–	1560
2022 Q3	$41K	Buy	11,335 +18	+0.2%	+$60	0.01%	1040
2022 Q2	$37K	Buy	+11,317	New	+$21.8K	0.02%	774
2022 Q1	–	Sell	-15,653	Closed	-$49K	–	989
2021 Q4	$49K	Buy	+15,653	New	+$65K	0.03%	568

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

XTX Topco's WVE Position: Q2 2026 in Review

XTX Topco increased its Wave Life Sciences (WVE) stake by 300% in Q2 2026, buying an estimated $2.19M and bringing the position to 439,933 shares worth $2.56M. The position accounts for 0.03% of the portfolio, ranked #876.

XTX Topco first reported a position in WVE in Q4 2021 and has held it in 10 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

XTX Topco held 439,933 shares of Wave Life Sciences worth $2.56M as of Q2 2026.
XTX Topco bought 330,071 Wave Life Sciences shares in Q2 2026, an estimated $2.19M.
Wave Life Sciences made up 0.03% of XTX Topco's portfolio in Q2 2026, its #876 holding.
XTX Topco first reported a position in Wave Life Sciences in Q4 2021 and has held it in 10 quarters since.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.